MYH9 and cancer: By weakening MYH9-actin interactions and deactivating these molecular motors, it promotes the mitochondrial division process, resulting in an imbalance in mitochondrial dynamics and a significant inhibition of cancer cell survival, proliferation, and migration (Qian et al., 2021).